Urist Marshall plan to sell securities of Royalty Pharma plc under Form 144

Urist Marshall filed Form 144 to notify SEC of plan to sell 9098 units of Royalty Pharma plc securities around 2026-06-24, with aggregate market value of $502,066.55. The total outstanding units is 443274104.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months include: On 05/14/2026, sold 13684 units for $726137.82; On 05/20/2026, sold 13684 units for $721837.21;